Section Arrow
FTH.NASDAQ
- Faeth Therapeutics Inc
Quotes are at least 15-min delayed:2026/08/02 15:29 EDT
Regular Hours
Last
 27.24
-1.58 (-5.48%)
Day High 
30.1 
Prev. Close
28.82 
1-M High
37.9 
Volume 
226.11K 
Bid
26.11
Ask
30.98
Day Low
26.26 
Open
29.51 
1-M Low
21.24 
Market Cap 
742.94M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 28.33 
20-SMA 28.87 
50-SMA 22.34 
52-W High 37.9 
52-W Low 7.2 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-142.72/-4.57
Enterprise Value
743.00M
Balance Sheet
Book Value Per Share
-5.33
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
REPLReplimune Group11.2+5.79+107.02%-- 
GOSSGossamer Bio0.1695-0.0088-4.94%-- 
JUNSJupiter Neurosciences Inc0.09-0.0075-7.69%-- 
KPTIKaryopharm Therapeutics Inc.1.92-5.09-72.61%-- 
IOVAIovance Biotherapeutics4.07-0.62-13.22%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.